NEW DELHI (Reuters) – Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday.
India also currently has no concern over the efficacy of the AstraZeneca vaccine that is being used in the country’s massive inoculation campaign, Vinod Kumar Paul said.
(Reporting by Krishna N. Das and Sai Sachin Ravikumar; Editing by Gareth Jones)
Flavor Flav is the official hype man for the US women’s water polo team in the Paris Olympics
Pacers’ Carlisle fined $35,000 by NBA for criticizing referees, implying bias against small markets
Series Preview: Phillies Splash down in the 305 to Face Marlins
Stanford names basketball court “Tara VanDerveer Court” for retired Hall of Famer, winningest coach
Miro Heiskanen scores 2 power-play goals and Stars beat Avs 5-3 in Game 2 to even series
Strong solar storm could disrupt communications and produce northern lights in US
Technology crushing human creativity? Apple’s new iPad ad has struck a nerve online
In reversal, Virginia school board votes to restore Confederate names to 2 schools
Bob Ross’ legacy lives on in new ‘The Joy of Painting’ series
Liam and Olivia are still the most popular US baby names, and Mateo makes his debut on the list
Virginia judge to decide whether state law considers embryos as property
No sign of widespread lead exposure from Maui wildfires, Hawaii health officials say
States with abortion bans saw greater drops in medical school graduates applying for residencies
Here’s what to know if you are traveling abroad with your dog
